Amyris, Inc. is a synthetic biotechnology and renewable chemical company headquartered in Emeryville, California. Amyris serves the specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals markets.[3]
Amyris was founded in 2003.[4] The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a sugar substitute. The company went public on NASDAQ on September 28, 2010 (AMRS).[5]
In November 2011, Amyris acquired Lansing, Michigan-based renewable chemicals and products company, Draths Corporation, for $7 million in stock.[6] ATEL Capital Group acquired a stake in Amyris in December 2011.[7] In January 2016, the company received an investment from the Bill & Melinda Gates Foundation's Strategic Innovation Fund to support the development of antimalarial medication based on semi-synthetic artemisinin.[8] In April 2019, the company raised $34-million in private placement of its common stock and warrants. The funding round was led by Foris Ventures and Dr. Wei-wu He, General Partner of Emerging Technology Partners, LLC, a life sciences-focused venture fund.[9]
Biossance, the skincare brand from Amyris, was recognized as Digital Innovator of the Year at the WWD Beauty Inc Awards in 2019.[10]
On August 9, 2023, Amyris filed for Chapter 11 bankruptcy protection and announced it will shut down its consumer brands amongst selling itself.[13] The company was delisted from Nasdaq and added to the OTC Markets.
^Brodwin, Erin. "After a kick-start from Bill Gates, a Silicon Valley company aims to be the 'Intel Inside' of the $200 billion sweetener and skincare market". Business Insider. Retrieved 2023-03-21.
^"Amyris, Inc. Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell". www.nasdaq.com. Retrieved 2020-06-30.
^Riddell, Lindsay (November 16, 2011). "Amyris buys chemicals-maker Draths". San Francisco Business Journal.
^Hilleman, Jeryl; Choksi, Paritosh K. (2011-12-23). "Amyris 2011 10-K Ex 4.07 Warrant to Atel". Securities and Exchange Commission. Archived from the original on 2023-12-24. Retrieved 2023-12-24.
^"Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine". Cision. 2020-10-20. from the original on 2023-12-24.
^"Amyris files for Chapter 11 bankruptcy protection in Delaware". Bloomberg Law. August 9, 2023. Retrieved August 10, 2023.
External linksedit
Official website
April 13, 2024
amyris, synthetic, biotechnology, renewable, chemical, company, headquartered, emeryville, california, amyris, serves, specialty, performance, chemicals, flavors, fragrances, cosmetics, ingredients, pharmaceuticals, nutraceuticals, markets, company, typepublic. Amyris Inc is a synthetic biotechnology and renewable chemical company headquartered in Emeryville California Amyris serves the specialty and performance chemicals flavors and fragrances cosmetics ingredients pharmaceuticals and nutraceuticals markets 3 Amyris Inc Company typePublicTraded asOTC Pink AMRSQNasdaq AMRSIndustryRenewable fuels antimalarials renewable chemicals renewable productsFounded2003HeadquartersEmeryville California USKey peopleJohn G Melo CEO Eduardo Alvarez COO Han Kieftenbeld CFO Nicole Kelsey Gen Counsel amp Secretary BrandsBiossance Pipette Purecane Costa Brazil EcoFabulous Rose Inc Terasana JVN and OLIKA Revenue 152 6 million FY 2019 1 Number of employees595 2021 2 SubsidiariesAmyris FuelsWebsitewww wbr amyris wbr comHistory editAmyris was founded in 2003 4 The company owns three brands Biossance and Pipette for beauty and skincare and Purecane a sugar substitute The company went public on NASDAQ on September 28 2010 AMRS 5 In November 2011 Amyris acquired Lansing Michigan based renewable chemicals and products company Draths Corporation for 7 million in stock 6 ATEL Capital Group acquired a stake in Amyris in December 2011 7 In January 2016 the company received an investment from the Bill amp Melinda Gates Foundation s Strategic Innovation Fund to support the development of antimalarial medication based on semi synthetic artemisinin 8 In April 2019 the company raised 34 million in private placement of its common stock and warrants The funding round was led by Foris Ventures and Dr Wei wu He General Partner of Emerging Technology Partners LLC a life sciences focused venture fund 9 Biossance the skincare brand from Amyris was recognized as Digital Innovator of the Year at the WWD Beauty Inc Awards in 2019 10 In 2020 Amyris received Bonsucro s Chain of Custody Certification ensuring that the sustainability claims along the sugarcane supply chain are traceable from farmer to end user 11 During the COVID 19 pandemic the company collaborated with the Infectious Disease Research Institute IDRI to advance a novel ribonucleic acid RNA vaccine platform including accelerating the development of a COVID 19 vaccine 12 On August 9 2023 Amyris filed for Chapter 11 bankruptcy protection and announced it will shut down its consumer brands amongst selling itself 13 The company was delisted from Nasdaq and added to the OTC Markets References edit Amyris Annual Report SEC filings Amyris profile Amyris Inc Company Profile Bloomberg com Brodwin Erin After a kick start from Bill Gates a Silicon Valley company aims to be the Intel Inside of the 200 billion sweetener and skincare market Business Insider Retrieved 2023 03 21 Amyris Inc Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell www nasdaq com Retrieved 2020 06 30 Riddell Lindsay November 16 2011 Amyris buys chemicals maker Draths San Francisco Business Journal Hilleman Jeryl Choksi Paritosh K 2011 12 23 Amyris 2011 10 K Ex 4 07 Warrant to Atel Securities and Exchange Commission Archived from the original on 2023 12 24 Retrieved 2023 12 24 Amyris Bill amp Melinda Gates Foundation Strategic Innovation Fund Archived from the original on 2023 12 24 Retrieved 2023 12 24 Coons Rebecca April 29 2019 Amyris raises 34 million as it pursues skin care sweeteners and CBD Nuu Biofuels Digest Nuu Media Writer December 17 2019 WWD Beauty Inc Names Biossance Brand Digital Innovator Of The Year markets businessinsider com Staff Amyris Sugarcane Is Traceable HAPPI Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform Beginning with COVID 19 Vaccine Cision 2020 10 20 Archived from the original on 2023 12 24 Amyris files for Chapter 11 bankruptcy protection in Delaware Bloomberg Law August 9 2023 Retrieved August 10 2023 External links editOfficial website Retrieved from https en wikipedia org w index php title Amyris Inc amp oldid 1208970272, wikipedia, wiki, book, books, library,
